Oncodesign Precision Medicine Société anonyme (ENXTPA: ALOPM)
Health Care · Biotechnology · FR
€0.34
+3.33% today · -24.2% 1Y
Oncodesign Precision Medicine Société anonyme (ENXTPA: ALOPM) operates in the Biotechnology industry within the Health Care sector. The company is valued at $7.30M.
Over the last twelve months the share price has lost 24.2%, trading between 0.20 and 0.92.
Tweenvest scores Oncodesign Precision Medicine Société anonyme across four factors: quality 63/100, value 43/100. Its strongest factor is quality.
ALOPM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.30M
- Revenue (TTM)
- $2.13M
- P/E
- 1.14
- EPS
- 0.30
- Dividend yield
- —
- Beta (5Y)
- -0.65
- 52-week high
- €0.92
- 52-week low
- €0.20
- Avg volume (3M)
- —
- Shares outstanding
- 19.04M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Oncotelic Therapeutics, Inc.OTCPK: OTLC | $7.59M | $0.02 | -20.19% |
| Ascelia Pharma AB (publ)OM: ACE | $7.58M | Skr0.56 | -34.65% |
| Aprea Therapeutics, Inc.NasdaqCM: APRE | $7.36M | $0.58 | -3.34% |
| Exicure, Inc.NasdaqCM: XCUR | $7.33M | $1.12 | +6.67% |
| Prostatype Genomics AB (publ)OM: PROGEN | $7.26M | Skr0.10 | +13.29% |
| Zeo ScientifiX, Inc.OTCPK: ZEOX | $7.14M | $0.91 | -23.11% |
| Senti Biosciences Holdings, Inc.NasdaqCM: SNTI | $7.00M | $0.22 | -28.47% |
| Rakovina Therapeutics Inc.TSXV: RKV | $6.93M | CA$0.22 | -2.22% |
Figures last refreshed Oct 18, 2026.